Engineered Pantoic Acid Strain for High-Purity Fermentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The synthesis of D-pantoic acid remains a limiting factor for the industrial-scale biological synthesis of calcium pantothenate due to the complex metabolic network regulation within wild-type Escherichia coli cells, which hinder high-purity pantoic acid accumulation.
Innovation Solution
A genetically engineered pantoic acid-producing strain with enhanced NADH-dependent acetohydroxy acid reductoisomerase and optimized enzyme activities in the pantoic acid production pathway, including acetolactate synthase, dihydroxy acid dehydratase, and 2-dehydropantoate-2-reductase, is developed to enhance D-pantoic acid production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If wild-type Escherichia coli cells are used for pantoic acid synthesis, then the metabolic network regulation is complex, but high-purity pantoic acid accumulation is hindered
Solution Approach 1:
The patent extracts and removes specific genes (ilvA, ilvI, ilvD, ilvB, ilvC, ilvN) from the wild-type E. coli metabolic network that are responsible for competing pathways and regulatory complexity. By deleting these genes, the metabolic network is simplified to favor pantoic acid accumulation, directly resolving the contradiction between manufacturing precision and device complexity
Solution Approach 2:
The patent introduces heterologous genes (acetohydroxy acid reductoisomerase from B. subtilis, 2-dehydropantoate-2-reductase from E. coli) to change the enzymatic parameters of the metabolic pathway. This parameter change enables the strain to overcome the inherent metabolic regulation barriers and achieve high-purity pantoic acid production
2Productivity
If petrochemical processes are used to prepare pantolactone, then production can be achieved, but severe environmental damage and high costs are caused
Solution Approach 1:
The patent replaces the mechanical/chemical petrochemical process with a biological fermentation system. Instead of using petrochemical feedstocks and chemical catalysts, the invention uses genetically engineered E. coli to biosynthesize pantoic acid through metabolic engineering, thereby eliminating the harmful environmental factors associated with petrochemical processes while maintaining productivity
Solution Approach 2:
The patent changes the fundamental parameter of raw material source from non-renewable petrochemical resources to renewable biological resources. The engineered strain uses glucose or other renewable carbon sources to produce pantoic acid, fundamentally altering the production system from environmentally harmful to environmentally friendly
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered strain achieves high-purity D-pantoic acid accumulation, reducing production costs and environmental impact by utilizing renewable resources, thus facilitating the production of calcium pantothenate.
Implementation Method 1
having or having enhanced NADH-dependent acetohydroxy acid reductoisomerase
Implementation Method 2
NADH-dependent acetohydroxy acid reductoisomerase
Implementation Method 3
capable of producing high-purity pantoic acid via microbial fermentation
Data Source
AI summary
The present invention provides a genetically engineered pantoic acid-producing strain having or having an enhanced NADH-dependent acetohydroxy acid reductoisomerase, a method for producing the strain, a method for producing D-pantoic acid using the strain, and use thereof in production of D-pantoic acid.